Description

BSE notifies trading members that Nexome Capital Markets Limited has fixed March 5, 2026 as the record date for a rights issue offering 1 new equity share for every 2 held at Rs. 75 per share (Rs. 10 face value + Rs. 65 premium).

Summary

BSE has informed trading members that Nexome Capital Markets Limited (Scrip Code: 508905) has fixed a record date for a rights issue of equity shares. Transactions in the company’s equity shares must be conducted on an ex-rights basis from March 5, 2026.

Key Points

  • Rights issue ratio: 1 new equity share for every 2 equity shares held
  • Issue price: Rs. 75 per share (face value Rs. 10 + premium of Rs. 65)
  • Record date: March 5, 2026
  • Ex-rights date: March 5, 2026 (Settlement No. DR-833/2025-2026)
  • Applicable segment: Dematerialised Securities – Rolling Settlement Segment
  • Notice issued by: Marian Dsouza, Assistant Vice President – Listing Compliance and Operations

Regulatory Changes

No new regulatory changes introduced. This circular implements standard exchange procedures under the existing rights issue framework for listed equity shares in the dematerialised rolling settlement segment.

Compliance Requirements

  • Trading members must ensure all transactions in Nexome Capital Markets Limited (508905) equity shares are executed on an ex-rights basis effective March 5, 2026.
  • Members should communicate the ex-rights status to clients transacting in this scrip on or after the effective date.

Important Dates

  • Record Date: March 5, 2026
  • Ex-Rights Effective Date: March 5, 2026
  • Settlement Number: DR-833/2025-2026
  • Circular Date: February 27, 2026

Impact Assessment

The rights issue affects existing shareholders of Nexome Capital Markets Limited who are eligible to subscribe to 1 new share for every 2 shares held at a price of Rs. 75 (including a premium of Rs. 65). The ex-rights date coincides with the record date (March 5, 2026), meaning buyers on or after that date will not be entitled to the rights. Market impact is limited to this single scrip and its existing shareholder base.

Impact Justification

Company-specific corporate action affecting existing shareholders of Nexome Capital Markets Limited; moderate impact limited to holders of scrip code 508905 who must act before the record date.